ログイン

Infectious disease.
65問 • 2年前
  • Quinn Karylle Fuentes
  • 通報

    問題一覧

  • 1

    It is when two organisms live intimatelyclose, typically over longer periods,often measured in generations for atleast one of the organisms

    Symbiosis.

  • 2

    If one organism is substantially smaller than the other organism and lives in oron the larger, then the larger organism is referred to as a host and the smaller asa symbiont

    Symbiosis.

  • 3

    A symbiosis in which both host and symbiont benefit

    Mutualism

  • 4

    A symbiosis in which one of the participants benefits (typically the symbiont) but the other organism neither benefits nor is harmed (typically thehost)

    Commensalism.

  • 5

    The third category of symbiosis, is one where the host is harmed while the lsymbiont gains (the latter, e.g. , byhaving a place to live and something toeat) .

    Parasitism.

  • 6

    The Normal microbata in humans is there internal organs are usually free of microorganisms (True/False)

    True.

  • 7

    But surface tissues have extensive populations of microorganisms

    Normal microbiota of humans.

  • 8

    The microbes that normally inhabit a healthy individual’s body are called microbiota or “normal flora”. (True/False)

    True.

  • 9

    Microbiota are specialists, able to colonize and survive on human tissue.

    Normal microbiota of humans.

  • 10

    Each body region has characteristic flora.

    Normal flora.

  • 11

    they are usually harmless and sometimes they are even beneficial.

    Normal flora.

  • 12

    Skin is not a great habitat it Dries out, constantly being shed, secretions include fatty acids (True/False)

    True.

  • 13

    What is the ph of the skin.

    4-6.

  • 14

    What are some skin regions better habitats than others.

    Scalp, ears, underarms and anal region.

  • 15

    acnes that can live in sweat glands, hair follicles, so it is not eliminated by washing skin.

    Propionibacterium.

  • 16

    expose sa environment, air, different surfaces na hinahawakan natin;

    Skin.

  • 17

    first line of defense also largest organ of the human body and it has a large surface area; hindi gaanong mataas ang moisture ng skin.

    Skin.

  • 18

    corny layers; top most layer; composed of dead cells na wala ng moisture.

    Stratum corneum.

  • 19

    propionibacterium acnes; causative agent of acne; propionic acid na ginagamit natin to lower the ph of our skin is used by them as food.

    Cutibacterium acnes.

  • 20

    They love sebum or yung oil na napoproduce sa mukha; usually sa adolescence

    Cutibacterium acnes.

  • 21

    primarily on our skin

    Staphylococcus epidermis.

  • 22

    can be found in our skin as well as in our nasal area; certain strains of s. aureus has the ability to eat some of our tissue.

    Staphylococcus aureus.

  • 23

    Saliva contains lysozymes and other enzymes that kill bacteria (True/False)

    True.

  • 24

    Streptococcus mutans and other Streptococcus adheres to teeth, especially gum margins, providing microhabitat for other bacteria to colonize. (True/False)

    True.

  • 25

    natutunaw sa acid and dahil doon nagkakaroon ng butas sa ngipin natin dahil sa mga microorganisms kaya nagkakaroon ng oral cavity.

    Tooth enamel.

  • 26

    a type of capsule that also allows other microorganisms to proliferate to our mouth; serve as a protection of microorganism.

    Biofilm.

  • 27

    Stomach is highly acidic (pH 2-3) and kills most microbes (True/False)

    True.

  • 28

    Some bacteria and yeasts can tolerate passage through the stomach; few microorganisms live in the stomach (True/False)

    True.

  • 29

    Small intestine has some bacteria, but does not proliferate due to digestive enzymes. (True/False)

    True.

  • 30

    As it approach colon, more and more bacteria can be seen, especially Gram-negative Enterobacter. (True/False)

    True.

  • 31

    Colon has an enormous bacterial population (1/3 of feces is bacteria) (True/False)

    True.

  • 32

    Bacteria in the colon divide every 12-24 hours on average, much slower than laboratory batch culture rates. (True/False)

    True.

  • 33

    Upper urinary tract is usually sterile (True/False)

    True.

  • 34

    Lower part of urethra gets some bacteria, but frequently "washed out" by urinary flow(True/False)

    True.

  • 35

    When washout is reduced, more chances of urinary tract infections (True/False)

    True.

  • 36

    Vagina has complex microbiota. After women start periods, glycogen is secreted, and lactic acid bacteria produce lactic acid, maintaining pH ~ 4.5.

    Genitourinary tract.

  • 37

    Disease occurs when this balance between the normal flora and the host is upset. (True/False)

    True.

  • 38

    An infection that results from a prior infection is called

    Secondary infection.

  • 39

    a microorganism that can survive in our stomach

    Helicobacter pylori.

  • 40

    main digestion

    Small intestine.

  • 41

    gram negative bacilli, rod shaped bacilli that harbors our gastrointestinal.

    Eschericia coli.

  • 42

    Sterile

    Bladder and urethra.

  • 43

    UTI means?

    Urinary Tract Infection.

  • 44

    harmless; di nag cacause ng sakit; can fight off bad bacteria

    Good bacteria.

  • 45

    it can kill a lot of groups of microorganism; pinapadami ang normal flora kapag namisuse kaya nag poproduce na ng toxin and nagkakaroon na ng diseases.

    Broad spectrum antibiotic.

  • 46

    if one bacteria prevents the growth or kills another form of bacteria.

    Antibiosis.

  • 47

    nagiging pathogenic siya kapag umalis siya sa git and napunta siya sa lungs; nagcacause sila ng sakit sa lungs specifically pneumonia.

    Klebsiella pneumoniae.

  • 48

    Broad spectrum antibiotic na kapag tinake ay mapapatay ang ibang microorganism maliban sa clostridium difficile and dadami ang clostridium difficile resulting to microbial overgrowth and usually nagkakaroon ng diarrhea and a specific disease pseudomembranous colitis.

    Clindamycin.

  • 49

    treatment of pseudomembranous colitis

    Vancomycin.

  • 50

    It is the prevention of harmful bacterial growth by a non-harmful bacterium.

    Microbial competition.

  • 51

    An organism existing in an area on or in the host fills the area and thus serves to prevent the filling of the same area by a harmful bacterium.

    Microbial competition.

  • 52

    Normal microbiota can benefit the host by preventing overgrowth of harmful microorganisms.

    Microbial competition.

  • 53

    In other words, the good bacteria help defend against the bad bacteria.

    Microbial competition.

  • 54

    Resident microflora are the more-or-less permanent members of normal microflora.

    Resident microbiota.

  • 55

    Transient microflora are present only under unusual circumstances and only transiently present (hours to months).

    Transient microbiota.

  • 56

    Opportunists are members of the normal microflora that do not usually cause disease but can be pathogenic under certain circumstances

    Opportunistic microorganisms.

  • 57

    study of the cause of the disease.

    Etiology.

  • 58

    Concerned with etiology as well as structural and functional changes brought about by the disease.

    Pathology.

  • 59

    Invasion and colonization of the body by pathogenic microorganisms.

    Infection.

  • 60

    it may exist in spite of an absence of detectable disease; so pag may infection tayo basta may bacterial growth, meron tayong infection but not necessarily namay sakit tayo.

    Infection.

  • 61

    Occurs when an infection results in any change from a state of health.

    Disease.

  • 62

    An abnormal state in which part or all of the body is incapable of performing normal functions.

    Disease.

  • 63

    An organism's capacity to cause disease.

    Pathogenicity.

  • 64

    The degree of disease an organism has the potential to cause disease.

    Virulence.

  • 65

    Growing the pathogen under conditions that decrease its adaptation to growth on a given host will decline the virulence of pathogen (attenuation).

    Virulence.

  • Cell structure.

    Cell structure.

    Quinn Karylle Fuentes · 28問 · 2年前

    Cell structure.

    Cell structure.

    28問 • 2年前
    Quinn Karylle Fuentes

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    Quinn Karylle Fuentes · 29問 · 2年前

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    29問 • 2年前
    Quinn Karylle Fuentes

    MW

    MW

    Quinn Karylle Fuentes · 45問 · 2年前

    MW

    MW

    45問 • 2年前
    Quinn Karylle Fuentes

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    Quinn Karylle Fuentes · 38問 · 2年前

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    38問 • 2年前
    Quinn Karylle Fuentes

    Density and specific gravity

    Density and specific gravity

    Quinn Karylle Fuentes · 34問 · 2年前

    Density and specific gravity

    Density and specific gravity

    34問 • 2年前
    Quinn Karylle Fuentes

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    Quinn Karylle Fuentes · 18問 · 2年前

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    18問 • 2年前
    Quinn Karylle Fuentes

    Microbial growth

    Microbial growth

    Quinn Karylle Fuentes · 63問 · 2年前

    Microbial growth

    Microbial growth

    63問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 61問 · 2年前

    Introduction.

    Introduction.

    61問 • 2年前
    Quinn Karylle Fuentes

    Microbial control.

    Microbial control.

    Quinn Karylle Fuentes · 97問 · 2年前

    Microbial control.

    Microbial control.

    97問 • 2年前
    Quinn Karylle Fuentes

    States of matter

    States of matter

    Quinn Karylle Fuentes · 100問 · 2年前

    States of matter

    States of matter

    100問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 86問 · 2年前

    Introduction.

    Introduction.

    86問 • 2年前
    Quinn Karylle Fuentes

    Drug development.

    Drug development.

    Quinn Karylle Fuentes · 77問 · 2年前

    Drug development.

    Drug development.

    77問 • 2年前
    Quinn Karylle Fuentes

    CGMP

    CGMP

    Quinn Karylle Fuentes · 9問 · 2年前

    CGMP

    CGMP

    9問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    Quinn Karylle Fuentes · 24問 · 2年前

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    24問 • 2年前
    Quinn Karylle Fuentes

    Powdered & granules

    Powdered & granules

    Quinn Karylle Fuentes · 43問 · 2年前

    Powdered & granules

    Powdered & granules

    43問 • 2年前
    Quinn Karylle Fuentes

    Capsule.

    Capsule.

    Quinn Karylle Fuentes · 24問 · 2年前

    Capsule.

    Capsule.

    24問 • 2年前
    Quinn Karylle Fuentes

    Tablets.

    Tablets.

    Quinn Karylle Fuentes · 23問 · 2年前

    Tablets.

    Tablets.

    23問 • 2年前
    Quinn Karylle Fuentes

    Calculatiom of dose

    Calculatiom of dose

    Quinn Karylle Fuentes · 66問 · 2年前

    Calculatiom of dose

    Calculatiom of dose

    66問 • 2年前
    Quinn Karylle Fuentes

    Postlab 5&6

    Postlab 5&6

    Quinn Karylle Fuentes · 29問 · 2年前

    Postlab 5&6

    Postlab 5&6

    29問 • 2年前
    Quinn Karylle Fuentes

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    Quinn Karylle Fuentes · 33問 · 2年前

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    33問 • 2年前
    Quinn Karylle Fuentes

    SEMI SOLID

    SEMI SOLID

    Quinn Karylle Fuentes · 69問 · 2年前

    SEMI SOLID

    SEMI SOLID

    69問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology

    Basic immunology

    Quinn Karylle Fuentes · 60問 · 2年前

    Basic immunology

    Basic immunology

    60問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology (2)

    Basic immunology (2)

    Quinn Karylle Fuentes · 62問 · 2年前

    Basic immunology (2)

    Basic immunology (2)

    62問 • 2年前
    Quinn Karylle Fuentes

    Transdermal

    Transdermal

    Quinn Karylle Fuentes · 44問 · 2年前

    Transdermal

    Transdermal

    44問 • 2年前
    Quinn Karylle Fuentes

    Distribution.

    Distribution.

    Quinn Karylle Fuentes · 43問 · 2年前

    Distribution.

    Distribution.

    43問 • 2年前
    Quinn Karylle Fuentes

    Infectious diseases (2)

    Infectious diseases (2)

    Quinn Karylle Fuentes · 79問 · 2年前

    Infectious diseases (2)

    Infectious diseases (2)

    79問 • 2年前
    Quinn Karylle Fuentes

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    Quinn Karylle Fuentes · 35問 · 2年前

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    Quinn Karylle Fuentes · 35問 · 2年前

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic ( Compressed)

    All topic ( Compressed)

    Quinn Karylle Fuentes · 30問 · 2年前

    All topic ( Compressed)

    All topic ( Compressed)

    30問 • 2年前
    Quinn Karylle Fuentes

    All topics (compressed)

    All topics (compressed)

    Quinn Karylle Fuentes · 13問 · 2年前

    All topics (compressed)

    All topics (compressed)

    13問 • 2年前
    Quinn Karylle Fuentes

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    Quinn Karylle Fuentes · 28問 · 2年前

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    28問 • 2年前
    Quinn Karylle Fuentes

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    Quinn Karylle Fuentes · 16問 · 2年前

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    16問 • 2年前
    Quinn Karylle Fuentes

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    Quinn Karylle Fuentes · 26問 · 2年前

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    26問 • 2年前
    Quinn Karylle Fuentes

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    Quinn Karylle Fuentes · 23問 · 2年前

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    23問 • 2年前
    Quinn Karylle Fuentes

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Quinn Karylle Fuentes · 35問 · 2年前

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    35問 • 2年前
    Quinn Karylle Fuentes

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    Quinn Karylle Fuentes · 20問 · 2年前

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    20問 • 2年前
    Quinn Karylle Fuentes

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    Quinn Karylle Fuentes · 33問 · 2年前

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    33問 • 2年前
    Quinn Karylle Fuentes

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    Quinn Karylle Fuentes · 37問 · 2年前

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    37問 • 2年前
    Quinn Karylle Fuentes

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    Quinn Karylle Fuentes · 23問 · 2年前

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    23問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae

    Enterobacteriaceae

    Quinn Karylle Fuentes · 35問 · 2年前

    Enterobacteriaceae

    Enterobacteriaceae

    35問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae.

    Enterobacteriaceae.

    Quinn Karylle Fuentes · 28問 · 2年前

    Enterobacteriaceae.

    Enterobacteriaceae.

    28問 • 2年前
    Quinn Karylle Fuentes

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    Quinn Karylle Fuentes · 31問 · 2年前

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    31問 • 2年前
    Quinn Karylle Fuentes

    Liquid dosage form

    Liquid dosage form

    Quinn Karylle Fuentes · 12問 · 2年前

    Liquid dosage form

    Liquid dosage form

    12問 • 2年前
    Quinn Karylle Fuentes

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    Quinn Karylle Fuentes · 44問 · 2年前

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    44問 • 2年前
    Quinn Karylle Fuentes

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    Quinn Karylle Fuentes · 22問 · 2年前

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    22問 • 2年前
    Quinn Karylle Fuentes

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    Quinn Karylle Fuentes · 40問 · 2年前

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    40問 • 2年前
    Quinn Karylle Fuentes

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    Quinn Karylle Fuentes · 29問 · 2年前

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    29問 • 2年前
    Quinn Karylle Fuentes

    Drug incompatibilities.

    Drug incompatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug incompatibilities.

    Drug incompatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    Drug compatibilities.

    Drug compatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug compatibilities.

    Drug compatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 35問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    35問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 30問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    30問 • 2年前
    Quinn Karylle Fuentes

    SUSPENSION.

    SUSPENSION.

    Quinn Karylle Fuentes · 45問 · 2年前

    SUSPENSION.

    SUSPENSION.

    45問 • 2年前
    Quinn Karylle Fuentes

    Colloidal.

    Colloidal.

    Quinn Karylle Fuentes · 40問 · 2年前

    Colloidal.

    Colloidal.

    40問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    Quinn Karylle Fuentes · 38問 · 2年前

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    38問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY.

    BACTERIOLOGY.

    Quinn Karylle Fuentes · 44問 · 2年前

    BACTERIOLOGY.

    BACTERIOLOGY.

    44問 • 2年前
    Quinn Karylle Fuentes

    Emulsion.

    Emulsion.

    Quinn Karylle Fuentes · 32問 · 2年前

    Emulsion.

    Emulsion.

    32問 • 2年前
    Quinn Karylle Fuentes

    EMULSION

    EMULSION

    Quinn Karylle Fuentes · 42問 · 2年前

    EMULSION

    EMULSION

    42問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    Quinn Karylle Fuentes · 36問 · 2年前

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    36問 • 2年前
    Quinn Karylle Fuentes

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    Quinn Karylle Fuentes · 33問 · 2年前

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    33問 • 2年前
    Quinn Karylle Fuentes

    Mycology.

    Mycology.

    Quinn Karylle Fuentes · 30問 · 2年前

    Mycology.

    Mycology.

    30問 • 2年前
    Quinn Karylle Fuentes

    Mycology 2.0

    Mycology 2.0

    Quinn Karylle Fuentes · 34問 · 2年前

    Mycology 2.0

    Mycology 2.0

    34問 • 2年前
    Quinn Karylle Fuentes

    m

    m

    Quinn Karylle Fuentes · 15問 · 2年前

    m

    m

    15問 • 2年前
    Quinn Karylle Fuentes

    ppr

    ppr

    Quinn Karylle Fuentes · 25問 · 2年前

    ppr

    ppr

    25問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    Quinn Karylle Fuentes · 20問 · 2年前

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    20問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    Quinn Karylle Fuentes · 86問 · 1年前

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    86問 • 1年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    Quinn Karylle Fuentes · 100問 · 1年前

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    100問 • 1年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    Quinn Karylle Fuentes · 19問 · 1年前

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    19問 • 1年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 17問 · 1年前

    Introduction.

    Introduction.

    17問 • 1年前
    Quinn Karylle Fuentes

    Introduction of biochemistry

    Introduction of biochemistry

    Quinn Karylle Fuentes · 76問 · 1年前

    Introduction of biochemistry

    Introduction of biochemistry

    76問 • 1年前
    Quinn Karylle Fuentes

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    Quinn Karylle Fuentes · 56問 · 1年前

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    56問 • 1年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 75問 · 1年前

    Carbohydrates

    Carbohydrates

    75問 • 1年前
    Quinn Karylle Fuentes

    Carbohydrates 1.1

    Carbohydrates 1.1

    Quinn Karylle Fuentes · 31問 · 1年前

    Carbohydrates 1.1

    Carbohydrates 1.1

    31問 • 1年前
    Quinn Karylle Fuentes

    Detect and quality variation.

    Detect and quality variation.

    Quinn Karylle Fuentes · 56問 · 1年前

    Detect and quality variation.

    Detect and quality variation.

    56問 • 1年前
    Quinn Karylle Fuentes

    INTRODUCTION

    INTRODUCTION

    Quinn Karylle Fuentes · 98問 · 1年前

    INTRODUCTION

    INTRODUCTION

    98問 • 1年前
    Quinn Karylle Fuentes

    lab (1-2)

    lab (1-2)

    Quinn Karylle Fuentes · 15問 · 1年前

    lab (1-2)

    lab (1-2)

    15問 • 1年前
    Quinn Karylle Fuentes

    lab 1-2

    lab 1-2

    Quinn Karylle Fuentes · 14問 · 1年前

    lab 1-2

    lab 1-2

    14問 • 1年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    Quinn Karylle Fuentes · 45問 · 1年前

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    45問 • 1年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    Quinn Karylle Fuentes · 35問 · 1年前

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    35問 • 1年前
    Quinn Karylle Fuentes

    Unit 3.

    Unit 3.

    Quinn Karylle Fuentes · 39問 · 1年前

    Unit 3.

    Unit 3.

    39問 • 1年前
    Quinn Karylle Fuentes

    Histamin and kinins

    Histamin and kinins

    Quinn Karylle Fuentes · 70問 · 1年前

    Histamin and kinins

    Histamin and kinins

    70問 • 1年前
    Quinn Karylle Fuentes

    PUD.

    PUD.

    Quinn Karylle Fuentes · 45問 · 1年前

    PUD.

    PUD.

    45問 • 1年前
    Quinn Karylle Fuentes

    ..

    ..

    Quinn Karylle Fuentes · 61問 · 1年前

    ..

    ..

    61問 • 1年前
    Quinn Karylle Fuentes

    Lipids.

    Lipids.

    Quinn Karylle Fuentes · 67問 · 1年前

    Lipids.

    Lipids.

    67問 • 1年前
    Quinn Karylle Fuentes

    lipids.

    lipids.

    Quinn Karylle Fuentes · 71問 · 1年前

    lipids.

    lipids.

    71問 • 1年前
    Quinn Karylle Fuentes

    LAB ✨

    LAB ✨

    Quinn Karylle Fuentes · 93問 · 1年前

    LAB ✨

    LAB ✨

    93問 • 1年前
    Quinn Karylle Fuentes

    Drug discovery.

    Drug discovery.

    Quinn Karylle Fuentes · 87問 · 1年前

    Drug discovery.

    Drug discovery.

    87問 • 1年前
    Quinn Karylle Fuentes

    disease of lipids.

    disease of lipids.

    Quinn Karylle Fuentes · 13問 · 1年前

    disease of lipids.

    disease of lipids.

    13問 • 1年前
    Quinn Karylle Fuentes

    Intro (identify structure)

    Intro (identify structure)

    Quinn Karylle Fuentes · 57問 · 1年前

    Intro (identify structure)

    Intro (identify structure)

    57問 • 1年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 98問 · 1年前

    Carbohydrates

    Carbohydrates

    98問 • 1年前
    Quinn Karylle Fuentes

    Dynamic.

    Dynamic.

    Quinn Karylle Fuentes · 96問 · 1年前

    Dynamic.

    Dynamic.

    96問 • 1年前
    Quinn Karylle Fuentes

    Unit 1

    Unit 1

    Quinn Karylle Fuentes · 32問 · 1年前

    Unit 1

    Unit 1

    32問 • 1年前
    Quinn Karylle Fuentes

    問題一覧

  • 1

    It is when two organisms live intimatelyclose, typically over longer periods,often measured in generations for atleast one of the organisms

    Symbiosis.

  • 2

    If one organism is substantially smaller than the other organism and lives in oron the larger, then the larger organism is referred to as a host and the smaller asa symbiont

    Symbiosis.

  • 3

    A symbiosis in which both host and symbiont benefit

    Mutualism

  • 4

    A symbiosis in which one of the participants benefits (typically the symbiont) but the other organism neither benefits nor is harmed (typically thehost)

    Commensalism.

  • 5

    The third category of symbiosis, is one where the host is harmed while the lsymbiont gains (the latter, e.g. , byhaving a place to live and something toeat) .

    Parasitism.

  • 6

    The Normal microbata in humans is there internal organs are usually free of microorganisms (True/False)

    True.

  • 7

    But surface tissues have extensive populations of microorganisms

    Normal microbiota of humans.

  • 8

    The microbes that normally inhabit a healthy individual’s body are called microbiota or “normal flora”. (True/False)

    True.

  • 9

    Microbiota are specialists, able to colonize and survive on human tissue.

    Normal microbiota of humans.

  • 10

    Each body region has characteristic flora.

    Normal flora.

  • 11

    they are usually harmless and sometimes they are even beneficial.

    Normal flora.

  • 12

    Skin is not a great habitat it Dries out, constantly being shed, secretions include fatty acids (True/False)

    True.

  • 13

    What is the ph of the skin.

    4-6.

  • 14

    What are some skin regions better habitats than others.

    Scalp, ears, underarms and anal region.

  • 15

    acnes that can live in sweat glands, hair follicles, so it is not eliminated by washing skin.

    Propionibacterium.

  • 16

    expose sa environment, air, different surfaces na hinahawakan natin;

    Skin.

  • 17

    first line of defense also largest organ of the human body and it has a large surface area; hindi gaanong mataas ang moisture ng skin.

    Skin.

  • 18

    corny layers; top most layer; composed of dead cells na wala ng moisture.

    Stratum corneum.

  • 19

    propionibacterium acnes; causative agent of acne; propionic acid na ginagamit natin to lower the ph of our skin is used by them as food.

    Cutibacterium acnes.

  • 20

    They love sebum or yung oil na napoproduce sa mukha; usually sa adolescence

    Cutibacterium acnes.

  • 21

    primarily on our skin

    Staphylococcus epidermis.

  • 22

    can be found in our skin as well as in our nasal area; certain strains of s. aureus has the ability to eat some of our tissue.

    Staphylococcus aureus.

  • 23

    Saliva contains lysozymes and other enzymes that kill bacteria (True/False)

    True.

  • 24

    Streptococcus mutans and other Streptococcus adheres to teeth, especially gum margins, providing microhabitat for other bacteria to colonize. (True/False)

    True.

  • 25

    natutunaw sa acid and dahil doon nagkakaroon ng butas sa ngipin natin dahil sa mga microorganisms kaya nagkakaroon ng oral cavity.

    Tooth enamel.

  • 26

    a type of capsule that also allows other microorganisms to proliferate to our mouth; serve as a protection of microorganism.

    Biofilm.

  • 27

    Stomach is highly acidic (pH 2-3) and kills most microbes (True/False)

    True.

  • 28

    Some bacteria and yeasts can tolerate passage through the stomach; few microorganisms live in the stomach (True/False)

    True.

  • 29

    Small intestine has some bacteria, but does not proliferate due to digestive enzymes. (True/False)

    True.

  • 30

    As it approach colon, more and more bacteria can be seen, especially Gram-negative Enterobacter. (True/False)

    True.

  • 31

    Colon has an enormous bacterial population (1/3 of feces is bacteria) (True/False)

    True.

  • 32

    Bacteria in the colon divide every 12-24 hours on average, much slower than laboratory batch culture rates. (True/False)

    True.

  • 33

    Upper urinary tract is usually sterile (True/False)

    True.

  • 34

    Lower part of urethra gets some bacteria, but frequently "washed out" by urinary flow(True/False)

    True.

  • 35

    When washout is reduced, more chances of urinary tract infections (True/False)

    True.

  • 36

    Vagina has complex microbiota. After women start periods, glycogen is secreted, and lactic acid bacteria produce lactic acid, maintaining pH ~ 4.5.

    Genitourinary tract.

  • 37

    Disease occurs when this balance between the normal flora and the host is upset. (True/False)

    True.

  • 38

    An infection that results from a prior infection is called

    Secondary infection.

  • 39

    a microorganism that can survive in our stomach

    Helicobacter pylori.

  • 40

    main digestion

    Small intestine.

  • 41

    gram negative bacilli, rod shaped bacilli that harbors our gastrointestinal.

    Eschericia coli.

  • 42

    Sterile

    Bladder and urethra.

  • 43

    UTI means?

    Urinary Tract Infection.

  • 44

    harmless; di nag cacause ng sakit; can fight off bad bacteria

    Good bacteria.

  • 45

    it can kill a lot of groups of microorganism; pinapadami ang normal flora kapag namisuse kaya nag poproduce na ng toxin and nagkakaroon na ng diseases.

    Broad spectrum antibiotic.

  • 46

    if one bacteria prevents the growth or kills another form of bacteria.

    Antibiosis.

  • 47

    nagiging pathogenic siya kapag umalis siya sa git and napunta siya sa lungs; nagcacause sila ng sakit sa lungs specifically pneumonia.

    Klebsiella pneumoniae.

  • 48

    Broad spectrum antibiotic na kapag tinake ay mapapatay ang ibang microorganism maliban sa clostridium difficile and dadami ang clostridium difficile resulting to microbial overgrowth and usually nagkakaroon ng diarrhea and a specific disease pseudomembranous colitis.

    Clindamycin.

  • 49

    treatment of pseudomembranous colitis

    Vancomycin.

  • 50

    It is the prevention of harmful bacterial growth by a non-harmful bacterium.

    Microbial competition.

  • 51

    An organism existing in an area on or in the host fills the area and thus serves to prevent the filling of the same area by a harmful bacterium.

    Microbial competition.

  • 52

    Normal microbiota can benefit the host by preventing overgrowth of harmful microorganisms.

    Microbial competition.

  • 53

    In other words, the good bacteria help defend against the bad bacteria.

    Microbial competition.

  • 54

    Resident microflora are the more-or-less permanent members of normal microflora.

    Resident microbiota.

  • 55

    Transient microflora are present only under unusual circumstances and only transiently present (hours to months).

    Transient microbiota.

  • 56

    Opportunists are members of the normal microflora that do not usually cause disease but can be pathogenic under certain circumstances

    Opportunistic microorganisms.

  • 57

    study of the cause of the disease.

    Etiology.

  • 58

    Concerned with etiology as well as structural and functional changes brought about by the disease.

    Pathology.

  • 59

    Invasion and colonization of the body by pathogenic microorganisms.

    Infection.

  • 60

    it may exist in spite of an absence of detectable disease; so pag may infection tayo basta may bacterial growth, meron tayong infection but not necessarily namay sakit tayo.

    Infection.

  • 61

    Occurs when an infection results in any change from a state of health.

    Disease.

  • 62

    An abnormal state in which part or all of the body is incapable of performing normal functions.

    Disease.

  • 63

    An organism's capacity to cause disease.

    Pathogenicity.

  • 64

    The degree of disease an organism has the potential to cause disease.

    Virulence.

  • 65

    Growing the pathogen under conditions that decrease its adaptation to growth on a given host will decline the virulence of pathogen (attenuation).

    Virulence.